Malignant teratoid medulloepithelioma with retinal invasion masquerading as vasoproliferative retinal tumor in an adult Authors: Rahul S. Nanduri, Vijitha S. Vempuluru, Mudit Tyagi, Saumya Jakati, Swathi Kaliki Published: 2026 ABSTRACT PurposeTo report a case of ciliary body medulloepithelioma with retinal invasion, in an older woman that closely mimicked a vasoproliferative retinal tumor resulting in initial misdiagnosis and management.ObservationsA 54-year-old female presented to the clinic with complaints of decreased vision in the left eye. Fundus examination of the left eye revealed a nasal exudative retinal detachment with peripheral retinal cystic lesion, and mildly tortuous veins draining an ill-defined pale lesion in the retinal periphery. Subsequently, the patient developed extensive peripheral subretinal exudation. With a presumptive diagnosis of peripheral retinal vasoproliferative tumor, the patient underwent multiple treatments including cryotherapy, scleral buckle placement, multiple vitrectomies, and membranectomies. Throughout the treatment course, ultrasound biomicroscopy was not performed since ciliary body origin of the pathology was never suspected. Three years later, the patient presented left painful blind eye and underwent left eye enucleation with implant. Histopathology revealed the diagnosis of a malignant teratoid medulloepithelioma with invasion into the iris, choroid, retina, sclera, and the extra-scleral tissues. Postoperatively, external-beam radiotherapy was delivered to the left orbit, and systemic surveillance did not reveal any systemic metastasis.Conclusions and importanceCiliary body medulloepithelioma with retinal invasion can rarely mimic retinal vasoproliferative tumor resulting in delayed diagnosis and appropriate treatment. High index of suspicion is needed for its diagnosis. Ultrasound biomicroscopy should be performed in all cases of peripheral retinal tumor to rule out ciliary body origin of the pathology. Introduction Medulloepithelioma is an extremely rare intraocular tumor that arises from the neuroepithelium. These tumors arise primarily from the ciliary body, although they have rarely been reported to arise from the optic nerve.1 The tumor has no recorded predilection for race, gender, or ocular laterality. About 5% are associated with pleuropulmonary blastoma syndrome, characterized by DICER1 gene mutations. Presentation is usually in the first decade of life, less commonly in the second.1,2 These tumors have rarely been reported in adults, with fewer than 100 cases reported in the literature, the earliest dating back to 1936.1, 2, 3, 4, 5, 6, 7, 8 In children, ciliary body medulloepithelioma (CBME) is most commonly misdiagnosed as retinoblastoma, glaucoma, endophthalmitis, or persistent hyperplastic primary vitreous.1,2 Because of its rare presentation in adults, it is often diagnosed on histopathology after enucleation of the affected eye.1, 2, 3, 4, 5, 6, 7, 8. Retinal invasion in CBME is extremely rare,9, 10, 11 especially so at initial presentation. Herein, we present a case of CBME with retinal invasion in a woman in her sixth decade, which closely resembled a vasoproliferative retinal tumor (VPRT), resulting in initial misdiagnosis and management. Case A 54-year-old female presented to the clinic with blurry vision in the temporal field of her left eye (OS) for 10 days. She was referred from elsewhere with a diagnosis of retinal detachment with peripheral neovascularization OS. She denied a history of trauma, and past medical history, surgical history, and family history were non-contributory. Visual acuity was 20/20 bilaterally (OU), and the anterior segment was unremarkable OU. Fundus examination was unremarkable in the right eye, whereas OS revealed a nasal exudative retinal detachment (Fig. 1A) with peripheral retinal cystic lesion and mildly tortuous veins draining an ill-defined pale lesion between 9:00 and 10:00 clock hours near the ora serrata (Fig. 1B). Ultrasonography B-scan showed a hyperechoic lesion measuring 5.0 x 5.0 × 3.0 mm with thickened retina and subretinal fluid (Fig. 1C). Optical coherence tomography of the macula showed a normal foveal contour (Fig. 1D).Fig. 1(A) to (D): Clinical picture at presentation.(A) Nasal exudative retinal detachment (asterisk) with (B) peripheral retinal cysts (arrowheads) and mildly tortuous veins (arrows) draining a pale lesion between 9:00 and 10:00 clock hours near the ora serrata. (C) Ultrasonography B-scan showed a hyperechoic lesion (asterisk) with thickened retina and subretinal fluid, and (D) optical coherence tomography of the macula showed a normal foveal contour.(E) to (H): Clinical picture following cryotherapy.(E) Three months after cryotherapy, the lesion remained stable (asterisk, but (F) optical coherence tomography showed an increase in subretinal fluid (five-point star) with involvement of the fovea. (G) The patient lost follow-up for 4 months and presented with worsening of subretinal fluid and extensive peripheral subretinal exudation surrounding the pinkish peripheral retinal lesion (arrows). (H) Improvement was noted following scleral buckle and pars plana vitrectomy.(I) to (J): Clinical picture, eight years from presentation.(I) Multiple intraocular interventions resulted in a painful red eye, (J) with intraocular silicone oil and no discernible details. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) (A) to (D): Clinical picture at presentation. (A) Nasal exudative retinal detachment (asterisk) with (B) peripheral retinal cysts (arrowheads) and mildly tortuous veins (arrows) draining a pale lesion between 9:00 and 10:00 clock hours near the ora serrata. (C) Ultrasonography B-scan showed a hyperechoic lesion (asterisk) with thickened retina and subretinal fluid, and (D) optical coherence tomography of the macula showed a normal foveal contour. (E) to (H): Clinical picture following cryotherapy. (E) Three months after cryotherapy, the lesion remained stable (asterisk, but (F) optical coherence tomography showed an increase in subretinal fluid (five-point star) with involvement of the fovea. (G) The patient lost follow-up for 4 months and presented with worsening of subretinal fluid and extensive peripheral subretinal exudation surrounding the pinkish peripheral retinal lesion (arrows). (H) Improvement was noted following scleral buckle and pars plana vitrectomy. (I) to (J): Clinical picture, eight years from presentation. (I) Multiple intraocular interventions resulted in a painful red eye, (J) with intraocular silicone oil and no discernible details. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) With a presumptive diagnosis of peripheral VPRT, three sessions of triple-freeze-thaw cryotherapy were performed. Post-cryotherapy, visual acuity remained 20/20 OS; subretinal fluid decreased; the lesion was not evident on indirect ophthalmoscopy; and the lesion remained stable on ultrasonography B-scan. The lesion was presumed to have regressed, and the patient was subsequently kept on periodic follow-up. Three months later, the patient presented with a sudden vision loss in the OS. Visual acuity dropped to 20/200 OS. The lesion remained nearly the same by ultrasound B-scan (Fig. 1E), but there was an increase in the subretinal fluid involving the macula (Fig. 1F). Pars plana vitrectomy (PPV) with endolaser and silicon oil injection was recommended but was deferred by the patient. Four months later, visual acuity had further deteriorated to 20/400 OS due to progressive retinal detachment. There was extensive peripheral subretinal exudation surrounding the pinkish nasal peripheral retinal lesion. (Fig. 1G). The patient underwent scleral buckle placement and pars plana vitrectomy for extensive vitreoretinal membranes. Perfluorocarbon liquid was used to settle the retina, and silicone oil was injected. One month later, her visual acuity was 20/80 OS, with nuclear cataract, persistent subretinal fluid, and a superior retinal break (Fig. 1H). The patient underwent OS phacoemulsification, pars plana vitrectomy, endolaser, and silicon oil exchange. Cryotherapy was repeated at the site of the lesion. Following surgery, her visual acuity was hand motion OS, with a shallow anterior chamber and inflammatory membranes. Over the following year, she underwent multiple vitrectomies and membranectomies for recurrent retinal detachments, inflammation, and retropupillary membranes, resulting in a digitally soft eye with an irregular anterior chamber, peripheral anterior synechiae, total posterior synechiae, and seclusio pupillae. Under operative microscopic visualization, there was an extensively scarred and contracted retina with membranes and no distinctly visible elevated lesion. On subsequent follow-ups over 3 years, the posterior segment could not be visualized, and the B-scan ultrasonography was noncontributory due to silicone oil. All surgeries involved a standard 3-port sutureless 25-G vitrectomy, and port sites were inspected at the end of the surgery. No cytological analysis was performed at any point, as malignancy was not suspected. Three years later, the patient presented to the Emergency Room with pain and watering of the OS for 3 days. Examination revealed light perception with inaccurate projection of rays OS, conjunctival congestion with dilated blood vessels, seclusio pupillae, an IOP of 30 mm Hg OS, and an oil-filled globe (Fig. 1I and J). Pain and discomfort persisted despite topical anti-glaucoma medications and steroids. And she eventually underwent OS enucleation with a polymethyl methacrylate implant in view of a painful blind eye. On gross examination, the sectioned eyeball showed a tan-colored mass obliterating the vitreous cavity and a disorganized anterior segment. Histopathological examination (Fig. 2) revealed a tumor arising from the ciliary body epithelium, infiltrating the entire ciliary body. Retinal architecture was completely lost and was replaced by the tumor cells. The lesion showed a diktyomatous pattern composed of anastomosing cords, bands, and ribbons of tumor cells in a background of acellular myxoid stroma. The tumor was invading the iris, choroid, sclera, and optic nerve. The anterior chamber showed necrosis, cholesterol clefts, foamy and pigmented macrophages, and tumor cells. Tumor cells were also noted to form a cyclitic membrane. Heterologous tissues, including hyaline cartilage with chondrosarcoma-like changes, glial tissue, rhabdomyoblasts, and sarcomatoid-differentiated areas, were observed, along with osseous metaplasia. These findings were consistent with a malignant teratoid medulloepithelioma with invasion into the iris, choroid, retina, sclera, and an extrascleral extension, posteriorly near the optic nerve. Postoperatively, 46 Gy external-beam radiotherapy was delivered to the orbit. Whole-body PET-CT did not reveal any systemic metastases. The patient is well with a customized ocular prosthesis OS at 6 months follow-up.Fig. 2(A) to (H): Photomicrographs of the enucleated eye.(A) Tumor arising from the ciliary body (inset, scanner view, asterisk) showing a diktyomatous pattern composed of anastomosing cords, bands, and ribbons of lesional cells in a background of acellular myxoid stroma (H&E, 7x). (B) Loss of retinal architecture, completely replaced by the tumor cells. (H&E, 6x, arrows), with (C) tumor invasion of the choroid (H&E, 6x), and (D) sclera (H&E, 5x).(E) Heterologous tissues, including areas of sarcomatoid differentiation (H&E, 20x), (F) rhabdomyoblasts (H&E, 10x), (G) chondrosarcoma-like changes (H&E, 20x), and (H) osseous metaplasia (H&E, 20x), were seen. (A) to (H): Photomicrographs of the enucleated eye. (A) Tumor arising from the ciliary body (inset, scanner view, asterisk) showing a diktyomatous pattern composed of anastomosing cords, bands, and ribbons of lesional cells in a background of acellular myxoid stroma (H&E, 7x). (B) Loss of retinal architecture, completely replaced by the tumor cells. (H&E, 6x, arrows), with (C) tumor invasion of the choroid (H&E, 6x), and (D) sclera (H&E, 5x).(E) Heterologous tissues, including areas of sarcomatoid differentiation (H&E, 20x), (F) rhabdomyoblasts (H&E, 10x), (G) chondrosarcoma-like changes (H&E, 20x), and (H) osseous metaplasia (H&E, 20x), were seen. Discussion The classic constellation of symptoms that raises suspicion for CBME includes leukocoria, lens changes, neovascularization, and a ciliary body mass with internal cysts in a child. However, CBME has a high rate of misdiagnosis, mainly due to the difficulty in directly visualizing the ciliary body mass until the neoplasm advances in size and severity, and the propensity of the tumor to cause secondary pathology, such as glaucoma, lens changes that may be misinterpreted as the primary pathology.1 Kaliki et al.’s study of 41 patients with CBME reports that glaucoma was present in 44% of cases and cataract in 46% of cases.2 In our case, several characteristics pointed towards a diagnosis of VPRT,12 including the patient's age, yellow-red tumor color, temporal location in peripheral retina, presence of exudative retinal detachment, and dilated retinal vessels draining the lesion. This unusual morphology, seen in our case, is likely due to retinal invasion of CBME. Clinically, this was evident in the form of a peripheral retinal tumor, subretinal cysts, and retinal vessels draining the lesion. The presence of retinal invasion was confirmed by histopathological examination later. Retinal invasion in CBME is rare, with only two detailed reports in the literature, and was not initially considered in our case.9,10 Carrillo and Streeten first documented retinal involvement in 1979, in a 43-year-old woman, high myope, with “glistening changes at the macula” that eventually progressed to “inoperable retinal detachment”, and a painful red eye from intractable glaucoma, and subsequently underwent enucleation. The diagnosis of CBME with diffuse retinal invasion was eventually established on histopathology.9 The second report by Font and Rishi, in 2005, describes a 27-year-old man who presented with iritis and vitritis hemorrhage, who was later discovered to have a ciliary body mass, which was excised by cyclectomy, but the histopathological examination was inconclusive due to insufficient material. He went on to develop a recurrent tumor, neovascular glaucoma, and subsequently underwent enucleation. Finally, the diagnosis of CBME with retinal invasion was confirmed on histopathology.10 In both cases, the onset of the tumor was in adulthood, and the diagnosis could not be established without histopathological examination of the enucleated eye, as in our case. In addition to these reports, Broughton and Zimmerman document a “retinal mass” in 2 cases among a series of 56 medulloepithelioma cases.11 Kivelä and Summamen discuss this as a “retinoinvasive phenotype” as seen with ciliary body melanomas, and discuss the factors associated with, or that may have led to, the retinal invasion of CBME including: (i) the presence of glaucoma, which is known to occur with ciliary body tumors aids in diverting the aqueous towards the posterior pole; (ii) necrotic tumor releases cells that float posteriorly in the aqueous; (iii) possibility of unusual clones that develop in longstanding tumors since the diagnosis is delayed in such cases.13 Of note, both patients in the reports discussed above had a significant systemic history with a benign ovarian tumor in the former and Hodgkin disease in the latter.9,10 Our patient presented in her 6th decade, but had no glaucoma at presentation, and no systemic associations, and the possibility of unusual clones may have existed. In retrospect, there were several clues suggesting the diagnosis of CBME with retinal invasion in our case. Given its peripheral location, performing ultrasound biomicroscopy may have provided insight into the ciliary body lesion. The presence of cysts in the retina was another important clue toward the diagnosis of CBME with retinal invasion. The other important clues included secondary glaucoma and recurrent retropupillary membranes. However, these can also occur with VPRT-associated inflammation and long-standing retinal detachments, making the diagnosis challenging. Another possible intervention, in retrospect, that may have led to the diagnosis was performing a cytological analysis of the vitrectomy fluid or membranectomy or samples, which was overlooked. A retinal biopsy could have also been performed at the time of vitrectomy. In summary, key takeaways from this case include: (i) Retinal invasion in CBME is a rare manifestation, and may be seen in adults (ii) CBME should be considered in the differentials of an atypical peripheral retinal lesion, with cystic changes at presentation or if unresponsive to conventional line of treatment, (iii) an ultrasound biomicroscopy is valuable in extreme peripheral retinal lesions, and (iv) cytological analysis following vitrectomy or membranectomy should be considered in any atypical case since this simple step may yield a definitive diagnosis in the early course of the disease especially in cases with equivocal clinical features. This report documents the fundoscopic appearance of retinal invasion in CBME. Although rare, this learning can aid ophthalmologists and ocular oncologists in establishing an early diagnosis and offering appropriate intervention. CRediT authorship contribution statement Rahul S. Nanduri: Writing – original draft, Data curation. Vijitha S. Vempuluru: Writing – review & editing, Project administration. Mudit Tyagi: Writing – review & editing, Methodology. Saumya Jakati: Writing – review & editing, Methodology, Investigation. Swathi Kaliki: Writing – review & editing, Validation, Project administration, Funding acquisition, Conceptualization. Patient consent Written consent to publish this case report has been obtained from the patient. Authorship All authors attest that they meet the current ICMJE criteria for Authorship. Funding The Operation Eyesight Universal Institute for Eye Cancer and Hyderabad Eye Research Foundation, Hyderabad, India; and Prateek Menezes Memorial Foundation, Goa, India, provided support. The funders had no role in preparing, reviewing, or approving the manuscript. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.